Neogen Corp (FRA:NG2)
€ 15 0.6 (4.17%) Market Cap: 3.32 Bil Enterprise Value: 4.04 Bil PE Ratio: 0 PB Ratio: 1.13 GF Score: 76/100

Neogen Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 05:00PM GMT
Release Date Price: €16.9 (+3.05%)
Edwin Zhang
J.P. Morgan Securities LLC - Analyst

Good morning. Welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is Edwin Zang. I'm a member of the JPMorgan healthcare team and the moderator for this session.

Today, I would like to introduce you to the team from Neogen. Please join me in welcoming our presenter, John Adent, CEO of Neogen.

John Adent
Neogen Corp - President & CEO

Thank you, everyone. It's very nice to be here, good to see you again. So good morning, everyone, and thank you for being here today. As Edwin said, I am John Adent, President and CEO of Neogen, and I will be providing an overview of Neogen for you this morning.

Just a quick reminder that in our presentation today, there will be some forward-looking statements. So at your leisure, please read our disclaimer.

I know that some of you may not be familiar with the Neogen story. So I wanted to spend a little time taking you through that. And really, what Neogen is about is we fuel a brighter future for global food security. That's what we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot